Mammalian Polyclonal IgG Antibody Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030

Published Date : Feb 2021 | No. of Pages : 250 Pages | Category : Healthcare

The global Mammalian Polyclonal IgG Antibody market size is expected to be worth around US$ 2.21 billion by 2030, according to a new report by Vision Research Reports.

The global Mammalian Polyclonal IgG Antibody market size was valued at US$ 916.5 million in 2020 and is anticipated to grow at a CAGR of 7.1% during forecast period 2021 to 2030.

Growth Factors

Advantages over other forms of antibodies, increasing global R&D investments, and rising adoption of novel diagnostic procedures are factors driving the market. Global rise in chronic and infectious diseases also play a key role in propelling the market growth.

Thus, increasing use of these products in the treatment of several chronic diseases is also anticipated to fuel growth in the near future. Rising investments by major pharma companies, such as Novartis and Roche, for the development of therapeutic antibodies and novel diagnostic techniques and for QC purposes are also driving the market growth. For instance, R&D investments by top 10 biotech companies increased from USD 8.2 billion in 2010 to USD 10.2 billion in 2016, accounting for a 13% increase.

Report Highlights

Based on product type, the mammalian IgG polyclonal antibody market is segmented into cardiac, metabolic, renal, and other biomarkers. Rising prevalence of Cardiovascular Diseases (CVDs) due to unhealthy eating habits, sedentary lifestyle, and lack of physical activity is driving the cardiac biomarkers segment. Metabolic biomarkers are used for testing a wide range of diseases. The segment is thus projected to expand at the highest CAGR of 5.5% during the forecast period.

Increasing use of metabolic biomarkers for diagnosis of diabetes is anticipated to propel its growth. The estimates from the International Diabetes Federation indicate that over 425 million people were suffering from diabetes globally in 2020. Type II diabetes is the most common type of diabetes and 90% of the affected population suffers from this type. Globally increasing cases of cancer are also anticipated to fuel the segment growth in near future. Other biomarkers taken into the consideration in the study are cancer, and autoimmune biomarkers.

Based on animal hosts, the market is segmented into goat, rabbit, horse, mouse, and others. The mouse segment is anticipated to exhibit the highest CAGR owing to predominant use of these animals for polyclonal antibody production. Antibody and antigen structural forms in humans and mice are similar, which is the prime reason for its increasing usage in research. Thus, mouse segment is expected to generate a significant revenue by 2025.

Rabbit antibodies, due to high specificity, showcase an enhanced immune response to small epitopes, facilitating increased recognition during disease diagnosis. Large variety of high-affinity antibodies produced by rabbits aids in finding immunoglobulins that have a wide range of applications, such as immunohistochemistry, ELISA, Western Blotting, immunocytochemistry, and others. This is anticipated to have a positive impact on the segment growth.

When large volume of antisera is required, antibodies are generally harvested from large animals, such as horses. Horses are also relatively better hosts for antibody production for several diseases including influenza, tuberculosis, Crohn’s disease, and asthma. Horse antisera has also been used for the treatment of tetanus, snake bites, and diphtheria among others. Mice are extremely useful for research on complex diseases due their similarities with humans. Thus, research on hypertension and atherosclerosis are mainly conducted using mice as host species. Due to all these factors, this segment is also anticipated to gain considerable market share in near future.

Application Insights

On the basis of application, the market is segmented into ELISA, immunoturbidometry, immunoelectrophoresis, antibody identification, immunohistochemistry, immunocytochemistry, and western blotting. Western blotting held the largest revenue in the year 2017, owing to its sensitivity and specificity. The use of Western Blotting facilitates disease detection with few antibodies, considerably reducing laboratory cost. Protein specificity of these tests is another key factor responsible for its increased demand.

However, the ELISA segment is anticipated to witness the highest CAGR of 5.8% over the forecast years due to its predominant use in antibody-related tests. It is the most often used test due to its accurate diagnosis of diseases, such as AIDS, Lyme disease, syphilis, pernicious anemia, and viral infections. The immunohistochemistry, used in tumor detection, is expected to account for a significant market share in the near future.

Based on end use, the market is divided into hospitals, diagnostic centers, and academic and research centers. Rising disease prevalence and increasing use of biomarkers for testing and diagnostic purposes are anticipated to influence the diagnostic centers segment growth. It held the largest market share owing to high usage of polyclonal antibodies for disease diagnosis. According to the World Health Organization (WHO), the incidence of tropical diseases, such as malaria, chikungunya, dengue, and yellow fever, has increased significantly, driving the demand for polyclonal antibodies.

Thus, diagnostic centers segment is anticipated to gain a significant market share during the forecast period. Academic and research centers generated a significant revenue in 2017 due to increased number of research activities on personalized medicine and improving drug efficacy. Hospitals held a considerable market share, owing to the high number of cases and diagnostic tests conducted in these settings. Rise in number of hospitals across the globe has also led to the growth of this segment. Growing need for hospitals with advanced facilities for detection of antigens in patient samples due to increasing prevalence of chronic diseases will also drive the segment.

Presence of government organizations, such as CDC, has contributed toward dominance of the regional market. Rising awareness among people and increasing R&D activities are some of the key factors contributing to the growth. Furthermore, collaborative programs between U.S. and China or biomedical research and increased research funding are expected to boost the market during the study period.

Asia Pacific (APAC) is anticipated to witness the highest growth during the forecast period owing to rising disposable income and increasing prevalence of cancer and diabetes. Growing focus of leading manufacturers on strengthening their presence in the emerging countries of APAC will also augment the regional market.Moreover, high demand for regenerative medicines and government support are expected to fuel growth in APAC.

For instance, the Japanese government provides funds to Okinawa Health Biotechnology Research and Development Center, an organization that provides free research facilities to eligible biotechnology companies. Thus, rising investments by pharmaceutical and biopharmaceutical companies coupled with high disease incidences are the factors driving the APAC regional market growth.

Key Players

Abcam PLC; Bio-Rad Laboratories; Thermo Fisher Scientific, Inc.; Merck KGaA; Cell Signaling Technology, Inc.; and F. Hoffman-La Roche. 

Market Segmentation

  • Type Outlook 

    • Goat

    • Rabbit

    • Horse

    • Mouse

    • Others

  • Product Outlook 

    • Cardiac Markers

    • Metabolic Markers

    • Renal Markers

    • Others

  • Application Outlook 

    • ELISA

    • Immunoturbidometry

    • Immunoelectrophoresis

    • Antibody Identification

    • Immunohistochemistry

    • Immunocytochemistry

    • Western Blotting

  • End Use Outlook 

    • Hospitals

    • Diagnostic Centers

    • Academic and Research Institutes

  • Regional Outlook 

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

      • Saudi Arabia

The Mammalian Polyclonal IgG Antibody market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Mammalian Polyclonal IgG Antibody market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Mammalian Polyclonal IgG Antibody market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mammalian Polyclonal IgG Antibody market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Mammalian Polyclonal IgG Antibody market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Mammalian Polyclonal IgG Antibody capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Mammalian Polyclonal IgG Antibody by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Mammalian Polyclonal IgG Antibody market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Mammalian Polyclonal IgG Antibody market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Mammalian Polyclonal IgG Antibody market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Mammalian Polyclonal IgG Antibody industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

The Mammalian Polyclonal IgG Antibody market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Mammalian Polyclonal IgG Antibody market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Mammalian Polyclonal IgG Antibody market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Mammalian Polyclonal IgG Antibody market. These factors have benefited the growth of the global market for Mammalian Polyclonal IgG Antibody. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Mammalian Polyclonal IgG Antibody. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Mammalian Polyclonal IgG Antibody are as follows:

  • Historic Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Featured Research Reports

  • Featured Research Reports

    Neuro-navigation Systems Market (By Product Type: Optical System, Electromagnetic System; By Application; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

  • Featured Research Reports

    Forensic Genomics Market (By Solution: Kits, Analyzers & Sequencers, Software, Consumables; By Method; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

  • Featured Research Reports

    Personalized Medicine Biomarkers Market (By Technology: Liquid Biopsy; By Application: Oncology, Cardiology) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

  • Featured Research Reports

    3D Printed Prosthetics Market (By Product Type: Sockets, Limbs, Joints, Covers; By Material; By End-Use)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

  • Featured Research Reports

    Vulvovaginal Candidiasis Treatment Market (By Drug Type: Clotrimazole, Nystatin, Fluconazole; By Route Of Administration; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030